Molecular Response Announces Key Agreement in Translational Oncology with OncoMed Pharmaceuticals

News   Feb 27, 2012

 
Molecular Response Announces Key Agreement in Translational Oncology with OncoMed Pharmaceuticals
 
 
 

RELATED ARTICLES

Nobel Prize for Chemistry 2017 Honors a Cool Revolution in Biochemistry

News

Cryo-EM allows the study of biomolecules at atomic resolution prepared under cryogenic conditions.

READ MORE

Screening for Disease or Toxins in a Drop of Blood

News

Scientist have developed a multinozzle emitter array (MEA), a silicon chip that can dramatically shorten the time it takes to identify proteins, peptides, and other molecular components within small volumes of biological samples.

READ MORE

Diabetic Ketoacidosis Assay Collaboration Between Ortho Clinical Diagnostics and EKF Diagnostics

News

EKF’s Beta-Hydroxybutyrate LiquiColor® Assay for detection of predominant ketone body now available on Ortho’s VITROS® 4600 Chemistry System and VITROS® 5600 Integrated System.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE